Physician profile
John Abdelsayed
NPI 1578983839
$16,344.76
in general payments reported to CMS, 2019-2025
20 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $197 · 2021: $653 · 2022: $304 · 2023: $1,340 · 2024: $1,867 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $4,647 · Travel and Lodging: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,029.80 |
| Food and Beverage | $4,647.31 |
| Travel and Lodging | $513.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $10,350.59 | 2024-2025 | Coolseal Generator |
| Abbvie INC. | $3,808.43 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps |
| Cytyc Surgical Products, LLC | $452.65 | 2025 | Coolseal Generator |
| Intuitive Surgical, INC. | $374.09 | 2021 | |
| Allergan, INC. | $352.64 | 2021-2022 | |
| Baxter Healthcare | $313.28 | 2024 | Perclot, Tisseel |
| Stryker Corporation | $161.07 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.69 | 2021 | |
| Medtronic, INC. | $109.46 | 2024-2025 | Interstim, Signia |
| Davol INC. | $45.49 | 2022 | |
| Baudax Bio INC. | $42.45 | 2021 | |
| Kerecis Limited | $35.80 | 2020 | |
| Tela Bio, INC. | $33.81 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Molnlycke Health Care US, LLC | $30.51 | 2025 | Avance |
| Aroa Biosurgery Incorporated | $24.02 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Activ Surgical, INC. | $22.49 | 2024 | Activsight |
| Integra Lifesciences Corporation | $22.23 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kowa Pharmaceuticals America, INC. | $19.32 | 2023 | Seglentis |
| Ethicon US, LLC | $17.61 | 2025 | Echelon; Endopath |
| Tactile Systems Technology INC | $17.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Abdelsayed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.